Form 4 for TWST Twist Bioscience Corp
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-12 · accession 0001214659-26-001737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-12 | TWST | Laponis Adam | CFO | S - Sale | $50.00 | -7,000 | 130.0K | -5% | -$350.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | S | D | 7,000 | $50.00 | 130,031 | D | — | — | (F1) The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025. |